Brief: Bioretec's Hybrid Composite Patent Approved In Europe
08/09/2022 15:02
Sept 8 (Reuters) - AstraZeneca PLC AZN.L :
* BIORETEC'S HYBRID COMPOSITE PATENT HAS BEEN APPROVED IN EUROPE
Source text for Eikon: ID:nWkr5v8PTc
Further company coverage: AZN.L
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million